Blackstone's $400 Million Bet on Teva: What Does the Smart Money Know That Most Investors Don't?
30/4 11:04
Key PointsBlackstone committed $400 million to fund development of Teva's promising autoimmune disease drug duvakitug....
|
|
|
30/4 11:04
Key PointsBlackstone committed $400 million to fund development of Teva's promising autoimmune disease drug duvakitug....